Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Cognex (CGNX) Asset Writedowns and Impairment (2020)

Cognex's Asset Writedowns and Impairment history spans 3 years, with the latest figure at $19.6 million for Q2 2020.

For the quarter ending Q2 2020, Asset Writedowns and Impairment changed N/A year-over-year to $19.6 million, compared with a TTM value of $19.6 million through Jul 2021, changed 0.0%, and an annual FY2020 reading of $19.6 million, changed N/A over the prior year.
Asset Writedowns and Impairment for Q2 2020 was $19.6 million at Cognex, up from $148000.0 in the prior quarter.
The five-year high for Asset Writedowns and Impairment was $19.6 million in Q2 2020, with the low at $19.6 million in Q2 2020.